Avidity Biosciences RNA Therapeutics 2024

Avidity Biosciences presents its RNA therapy platform and clinical development programs, including the AOC platform for treating rare diseases. The presentation covers product candidates in development, including delpacibart etedesiran and addresses regulatory developments including a partial clinical hold.